AJP - Lung Cellular and Molecular Physiology, Vol 267, Issue 3 326-L334, Copyright © 1994 by American Physiological Society

ARTICLES

Contraction of human bronchial smooth muscle caused by activated human eosinophils

K. F. Rabe, N. M. Munoz, A. J. Vita, B. E. Morton, H. Magnussen and A. R. Leff
Krankenhaus Grosshansdorf, Zentrum fur Pneumologie und Thoraxchirurgie, LVA Hamburg, Germany.

We assessed the effect of activated eosinophils isolated from human peripheral blood in causing contraction of explanted human bronchi in vitro. Sixty-three epithelium-intact fifth generation airway sections were obtained from 16 subjects undergoing lung resection for carcinoma. Eosinophils were isolated by negative immunoselection, and activation with 10(-7) M platelet-activating factor (PAF) was confirmed by measurements of eosinophil peroxidase (EPO) secretion and superoxide (O2-.) generation. EPO secretion increased from 68.6 +/- 13.4 ng/10(6) cells to 420 +/- 125 ng/10(6) cells after activation with PAF (P < 0.05). Similarly, PAF-induced O2-. generation increased from 15.3 +/- 4.64 nmol cytochrome c reduced/10(5) cells to 44.2 +/- 8.50 nmol cytochrome c reduced/10(5) cells (P < 0.05). Cells were instilled into an isolated airway pouch preparation, and, 60 min later, airway contractile responses were determined by optical micrometry as percent decrease in lumenal diameter (%decrease) and percent increase in wall thickness (%increase) using a calibrated magnifying lens. Treatment with either vehicle, PAF alone, or untreated eosinophils had no effect on airway caliber or thickness. PAF-activated cells caused a 30.5 +/- 1.52% decrease in airway caliber (P < 0.001 vs. untreated cells) and a 36.6 +/- 2.54% increase in wall thickness (P < 0.001 vs. untreated cells). Preincubation with A63162, a 5-lipoxygenase inhibitor, caused concentration-dependent inhibition of airway narrowing. After 10(-5) M A63162, decrease in airway diameter caused by PAF was 8.00 +/- 0.10% vs. 30.5 +/- 1.52% for PAF alone (P < 0.01).(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				J. G. Zangrilli Regulation of Eosinophil Viability by Cytokines Am. J. Respir. Cell Mol. Biol., April 1, 2002; 26(4): 388 - 390. [Full Text] [PDF]

				J. BOUSQUET, P. K. JEFFERY, W. W. BUSSE, M. JOHNSON, and A. M. VIGNOLA Asthma . From Bronchoconstriction to Airways Inflammation and Remodeling Am. J. Respir. Crit. Care Med., May 1, 2000; 161(5): 1720 - 1745. [Full Text]

				D. SCHMIDT and K. F. RABE The Role of Leukotrienes in the Regulation of Tone and Responsiveness in Isolated Human Airways Am. J. Respir. Crit. Care Med., February 1, 2000; 161(2): S62 - 67. [Full Text] [PDF]

				A. SANO, N. M. MUÑOZ, H. SANO, J. CHOI, X. ZHU, B. JACOBS, and A. R. LEFF Inhibition of cPLA2 Translocation and Leukotriene C4 Secretion by Fluticasone Propionate in Exogenously Activated Human Eosinophils Am. J. Respir. Crit. Care Med., June 1, 1999; 159(6): 1903 - 1909. [Abstract] [Full Text]

				M. Nagata, J. B. Sedgwick, H. Kita, and W. W. Busse Granulocyte Macrophage Colony-stimulating Factor Augments ICAM-1 and VCAM-1 Activation of Eosinophil Function Am. J. Respir. Cell Mol. Biol., July 1, 1998; 19(1): 158 - 166. [Abstract] [Full Text]

				M. E. Bates, W. W. Busse, and P. J. Bertics Interleukin 5 Signals through Shc and Grb2 in Human Eosinophils Am. J. Respir. Cell Mol. Biol., January 1, 1998; 18(1): 75 - 83. [Abstract] [Full Text]

				G. Dent, N. M. Muñoz, E. Rühlmann, X. Zhu, A. R. Leff, H. Magnussen, and K. F. Rabe Protein Kinase C Inhibition Enhances Platelet-activating Factor-induced Eicosanoid Production in Human Eosinophils Am. J. Respir. Cell Mol. Biol., January 1, 1998; 18(1): 136 - 144. [Abstract] [Full Text]

				A. Garland, J. Necheles, S. R. White, S. P. Neeley, A. R. Leff, S. S. Carson, L. E. Alger, K. McAllister, and J. Solway Activated eosinophils elicit substance P release from cultured dorsal root ganglion neurons Am J Physiol Lung Cell Mol Physiol, November 1, 1997; 273(5): L1096 - L1102. [Abstract] [Full Text] [PDF]